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Abstract
Background: UV-induced damage can induce apoptosis or trigger DNA repair mechanisms.
Minor DNA damage is thought to halt the cell cycle to allow effective repair, while more severe
damage can induce an apoptotic program. Of the two major types of UV-induced DNA lesions, it
has been reported that repair of CPD, but not 6-4PP, abrogates mutation. To address whether the
two major forms of UV-induced DNA damage, can induce differential biological effects, NER-
deficient cells containing either CPD photolyase or 6-4 PP photolyase were exposed to UV and
examined for alterations in cell cycle and apoptosis. In addition, pTpT, a molecular mimic of CPD
was tested in vitro and in vivo for the ability to induce cell death and cell cycle alterations.
Methods:  NER-deficient XPA cells were stably transfected with CPD-photolyase or 6-4PP
photolyase to specifically repair only CPD or only 6-4PP. After 300 J/m2  UVB exposure
photoreactivation light (PR, UVA 60 kJ/m2) was provided for photolyase activation and DNA repair.
Apoptosis was monitored 24 hours later by flow cytometric analysis of DNA content, using sub-
G1 staining to indicate apoptotic cells. To confirm the effects observed with CPD lesions, the
molecular mimic of CPD, pTpT, was also tested in vitro and in vivo for its effect on cell cycle and
apoptosis.
Results: The specific repair of 6-4PP lesions after UVB exposure resulted in a dramatic reduction
in apoptosis. These findings suggested that 6-4PP lesions may be the primary inducer of UVB-
induced apoptosis. Repair of CPD lesions (despite their relative abundance in the UV-damaged cell)
had little effect on the induction of apoptosis. Supporting these findings, the molecular mimic of
CPD, (dinucleotide pTpT) could mimic the effects of UVB on cell cycle arrest, but were ineffective
to induce apoptosis.
Conclusion: The primary response of the cell to UV-induced 6-4PP lesions is to trigger an
apoptotic program whereas the response of the cell to CPD lesions appears to principally involve
cell cycle arrest. These findings suggest that CPD and 6-4 PP may induce differential biological
effects in the UV-damaged cell.
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Background
More than one million cases of skin cancer are diagnosed
in the U.S. annually, resulting in 9,600 deaths, 7,400 of
which are from metastatic melanoma [1]. Absorption of
ultraviolet (UV) light produces two predominant types of
DNA damage, cyclobutane pyrimidine dimers (CPD) [2]
and pyrimidine (6-4) pyrimidone photoproducts (6-4PP)
[3]. The result is a transition of C to T and CC to TT [4],
which are the most frequent mutations of p53 in both
human and mouse skin cancers [5,6]. UV damaged DNA
causes torsional strain and is usually repaired by nucle-
otide excision repair (NER) or base excision repair (BER).
After UV exposure, cells activate p53 and stall the cell cycle
for repair [7,8]. If the damage is too severe, the cell will
trigger apoptosis to get rid of a DNA damaged, potentially
mutant cell [9]. But how does the cell determine when
UV-damaged DNA can be repaired or when apoptosis
should be initiated?
Previous studies have reported that CPD, but not 6-4PP,
lesions are the major source of lasting UV-induced muta-
tions [10], as CPD is usually at a 5 to 10 fold higher fre-
quency than 6-4PP [11,12]. The repair of CPD lesions by
exogenous CPD photolyase has been shown to reduce
apoptosis both in vivo [13] and in vitro [14], but such stud-
ies did not examine the effect of 6-4PP lesions. Indeed,
most previous studies have assumed that the amount of
DNA damage is the deciding factor in a cell's fate with
both lesions weighing in equally for biologic effect.
In this study, we have investigated whether UV-induced
CPD and 6-4PP DNA damage have differential effects on
the induction of apoptosis and cell-cycle arrest. To control
DNA repair in UV-exposed human cells we have used
photolyases, the DNA repair enzymes that are employed
widely in the animal kingdom, but not in man [15]. Bac-
teria, fungi, plants, invertebrates, and many vertebrates,
but not humans, use photolyases to repair UV-induced
DNA damage [15,16]. This light-dependent (360–420
nm, visible~UVA) photolyase mediated repair of CPD or
6-4PP is referred to as photoreactivation (PR). By express-
ing photolyases in NER-defective cells we have been able
to individually analyze the impact of residual CPD and 6-
4PP lesions on apoptosis and cell cycle. Our findings
demonstrate that the "type" of DNA lesion is as important
as the total "amount" of damaged DNA in the balance of
life and death, as it relates to apoptosis after UVB
exposure.
Materials and methods
Chemicals and Cell Culture
All chemicals were purchased from Sigma (St. Louis, MO)
unless otherwise noted. The SV40-transformed human
cell line derived from an XPA patient, XP12ROSV, was sta-
bly transfected with expression vectors containing cDNAs
for either 6-4PP photolyase, CPD photolyase, both types
of photolyases, or empty vector controls as previously
described [10,17]. Cells were maintained in Eagle's mini-
mum essential medium (MEM) containing 10% heat-
inactivated fetal bovine serum, 2 mM L-glutamine, 1 mM
sodium pyruvate, 100 units/ml penicillin, 100 µg/ml
streptomycin, 1× MEM vitamins solution, and 1× MEM
non-essential amino acids at 37°C in a humidified 5%
CO2 incubator.
UV-irradiation and photoreactivation
Twenty-four hours prior to UV-irradiation, media was
changed to phenol-red free culture medium to prevent the
absorption of energy by phenol red. The UV source used
was a Spectrolinker XL-1000 (Spectronics Corp., West-
bury, NY) containing five 8-watt UV tubes. Two different
UV wavelength tube sets were used, UVA 365 nm, and
UVB 312 nm. For induction of DNA damage and apopto-
sis, cells were irradiated at 300 J/m2 UVB in 100 mm cell
culture dishes without lids. After irradiation, cells were
treated with UVA, which serves as photo-reactivation
energy for photolyase activity (30 min, 60 kJ/m2). Follow-
ing treatments, cells were incubated for 24 h prior to har-
vesting. Cells were harvested by washing with pre-warmed
PBS and adding trypsin for 2 min. Cell pellets were col-
lected after centrifugation at 1000 × g for 5 min.
Radio-immunoassay (RIA) of 6-4PP and CPD
Genomic DNA from UV exposed cells was isolated with a
Wizard Genomic DNA purification kit (Promega, Madi-
son, WI) 12 hours after 300 J/m2 UVB irradiation. UV-
induced DNA damage was detected using specific anti-
bodies and a radioimmunoassay described previously
[18].
DNA damage detection by Immuno-Dot-Blot
The repair of CPD and 6-4PP lesions after photoreactiva-
tion was measured by an Immuno-Dot-Blot assay using
the CPD-specific monoclonal antibody and the 6-4PP-
specific monoclonal antibody (Kamiya Biomedical, WA).
After UV treatment and PR, cellular DNA was isolated and
then denatured in TE buffer (10 mM Tris-CL and 1 mM
EDTA, pH 7.5) by boiling for 5 min. Thesamples were dot-
blotted onto a Hybond N+ membrane (Amersham, NJ)
using 200 ng of DNA for the CPD assay and 1 µg of DNA
for the 6-4PP assay. The membrane was dried by baking
on a 80°C plate for 1 hour then DNA was fixed to the
membrane for 20 min by soaking in 0.4 N NaOH on a fil-
ter paper. The membranes were blocked overnight in
phosphate-buffered saline, 0.2% Tween 20 (PBS-T) con-
taining 5% (w/v) skim milk. After washing in PBS-T, the
membranes were incubated for 2 h at room temperature
with anti 6-4PP antibody and anti CPD monoclonal anti-
body. After washing, membranes were incubated for 1 h
with peroxidase conjugated goat anti-mouse antibodyBMC Cancer 2005, 5:135 http://www.biomedcentral.com/1471-2407/5/135
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(Jackson ImmunoResearch, PA). Signals were detected
with a chemiluminescence kit (Amersham, NJ).
Western blot
Whole cell lysates were prepared from pelleted cells in
lysis buffer [20 mM Tris-HCl (pH 8.0), 150 mM sodium
chloride, 10% glycerol, 1% Triton-X 100, 2 mM sodium
orthovanadate, 2 mM EDTA and 1× complete protease
inhibitor cocktail (Roche, Germany)]. Total protein con-
centrations in lysate preparations were determined using
a BCA assay and 15 µg total protein was loaded in each
lane of a 10% SDS-PAGE gel. Proteins were resolved by
electrophoresis and blotted onto nitrocellulose mem-
branes (Hybond ECL, Amersham Pharmacia Biotech,
Buckinghamshire, United Kingdom). Blots were blocked
with 5% milk in PBS for 1 h prior to incubation with pri-
mary antibodies. To confirm photolyase expression, blots
were probed with rabbit antibodies specific for 6-4PP
photolyase or CPD photolyase (Dr. Yasui, Tohoku Uni-
versity, Sendai, Japan). The blots were washed 3× with
PBST (0.5% Tween 20) and incubated with secondary per-
oxidase-conjugated goat anti-rabbit antibodies for 1 h
(Jackson ImmunoResearch Laboratories, Inc., West
Grove, PA). Blots were rinsed 3× with PBST and antibody
binding was detected with ECL (Amersham Pharmacia
Biotech).
Flow cytometric measurement of cell cycle and apoptosis
Following UV or pTpT treatment, cells were harvested and
fixed in 70% ethanol at -20°C overnight. Cells were then
pelleted and resuspended in 125 µl of PBS containing
0.2% Triton X-100 solution and 12 Kunitz units of ribo-
nuclease A (Sigma) for 15 min at room temperature, fol-
lowed by the addition of 130 µl propidium iodide (PI) at
0.1 mg/ml. Cells were maintained in the dark and ana-
lyzed by flow cytometry using a Becton Dickinson FACS-
can (San Jose, CA). After excluding cell debris and
doublets, DNA content and cell cycle were analyzed using
Cellquest-Pro software. Cells showing DNA content less
than the peak for G1/G0 were considered sub-diploid and
apoptotic.
Mimic of damaged DNA by pTpT
Thymidine dinucleotides, pTpT, (Midland Certified Rea-
gent, Midland, TX) were used to mimic UV-induced DNA
damage. In vitro, 100 µM pTpT was added to Jurkat cell
culture medium, the same concentration of adenosine
dinucleotides (pApA) was used for a negative control.
Cells were harvested 1 h or 24 h after treatment to exam-
ine cell cycle. For in vivo studies, pTpT and pApA were dis-
solved in propylene glycol and 100 µl was applied to the
shaved backs of C57BL/6 mice to cover an area at 200 µM
per 2 cm2 (Jackson Labs, Bar Harbor, ME). All mouse stud-
ies were performed in accordance with NIH and Institu-
tional Animal Care and Use Committee guidelines. The
skin was shaved 24 hours before treatment. Mice were
exposed to a single dose of 4 kJ/m2 UVB as positive con-
trols. Mice were sacrificed 24 hours after treatment, with 3
mice for each treatment and 3 independent experiments
performed. Formaldehyde-fixed skin biopsies were paraf-
fin embedded. Seven-micron sections were made with a
microtome and mounted onto charged glass slides. Apop-
tosis was assessed by staining for DNA fragmentation
using the DeadEnd Fluorometric TUNEL System
(Promega, Madison, WI). All TUNEL-positive cells in the
epidermis of each section were counted using a fluores-
cence microscope. Each counted section was measured for
length using calipers and using an apoptotic index gener-
ated to show the number of TUNEL-positive cells per unit
of length.
Results and discussion
CPD is the dominant DNA lesion in NER-deficient cells 
after UVB irradiation
XPA cells mutated in the xpa gene cannot perform nucle-
otide excision repair (NER) and therefore accumulate
large amounts of UV-induced DNA damage after UVB
exposure. XPA cells were irradiated with 300 J/m2 UVB
and assayed for UV-induced DNA damage using muta-
tion-specific radioimmunoassays (RIA). The 300 J/m2
UVB dose was chosen as there was little acute, UV-induced
oxidative cell death induced under these conditions,
while there was sufficient levels of DNA damage to repro-
ducibly measure decreases following photolyase repair
(doses between 50~1500 J/m2 were screened initially).
Because 6-4PP lesions occur at a lower frequency than
CPD lesion, the 300 J/m2 dose was chosen as the lowest
dose of UVB that produced high enough numbers of 6-
4PP lesions such that repair could be accurately measured
following photolyase treatment (>10 lesions per 106 DNA
pairs). At this UVB dose, a substantial number of CPD
lesions were observed (averaging 55 CPD per 106 DNA
pairs) and fewer, but reproducible number of 6-4PP
lesions (averaging at 12 6-4PP per 106 DNA pairs). The
average number of lesions in unrepaired cells in two inde-
pendent experiments is shown in Figure 1. Our results
show that CPD are the predominant UV-induced DNA
lesions and are approximately five-fold more prevalent
than 6-4PP. These results are consistent with other studies
that show 6-4PP lesions occur at 15–30% the frequency of
CPD lesion following UV damage [12].
Repair of 6-4PP significantly reduces apoptosis
We examined the effects of repairing either CPD or 6-4PP
lesions by stably expressing photolyase cDNAs in XPA
cells. Several studies have shown that these photolyase
enzymes can efficiently and specifically repair DNA
lesions within one hour when provided with photo-reac-
tivation light [10,14,19]. Stable expression and function
of each photolyase in XPA cells was confirmed by westernBMC Cancer 2005, 5:135 http://www.biomedcentral.com/1471-2407/5/135
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blot and immuno-dot blot (Fig 2). XPA cells expressing 6-
4PP-PL only repair 6-4PP type lesions, vice versa, CPD-PL
only repair CPD type lesions (Fig 2C and 2D). Using this
system we were able to independently repair one kind of
lesion and thereby examine the biological effects of the
other in relative isolation. Background apoptosis of XPA
cells, as measured by sub-G1 DNA, is 1–3% for non-irra-
diated cells. Twenty-four hours after exposure to UVB and
PR (60 kJ/m2 UVA), 20.9% of empty vector transfected
cells were apoptotic. UV-exposed XPA cells that expressed
both photolyases and received PR, showed only 5.3%
apoptosis, a reduction of approximately 75%. Cells
expressing only one of the photolyases showed consider-
ably different responses depending upon which enzyme
was expressed. Repair of 6-4PP lesions reduced apoptosis
to 6.6%, while repair of CPD lesions only reduced apop-
tosis to 12.9%. Although CPD is the major type of UV-
induced DNA lesion (82%, about five times more than 6-
4PP) repair of CPD only reduces apoptosis by 40% (Fig
3). In contrast, 6-4PP lesions comprise only 18% of UVB-
induced DNA lesions, but account for 70% of the apopto-
sis (Fig 3). Indeed, repairing 6-4PP lesions alone sup-
pressed apoptosis as much as repairing both types of DNA
lesions. Similar findings were observed when Annexin V
was used to measure apoptotic responses; suggesting that
both sub-diploid DNA and phosphatidylserine exposure
on the outer membrane leaflet are impacted by photol-
yase repair (data not shown). These findings indicate that
6-4PP lesions are more potent inducers of apoptosis than
CPD lesions.
The CPD mimic, pTpT, stalls the cell cycle but does not 
significantly induce apoptosis
UV exposure induces mainly CPD lesions (Fig. 1) that are
typically repaired by NER. Thymidine dinucleotides, pTpT
a mimic of CPD, are structurally similar to the small DNA
fragments released during NER and have been reported to
mimic UV-damaged DNA by activating p53 and prolifer-
ating cell nuclear antigen (PCNA) to enhance DNA repair
[20]. These dinucleotides have also been reported to
mimic damaged DNA and to increase melanogenesis [21]
in normal human melanocytes and in human melanoma
cells. The monomeric form of thymidine, pT, [22] or
Radio-immunoassay (RIA) of UV-induced 6-4PP and CPD Figure 1
Radio-immunoassay (RIA) of UV-induced 6-4PP and 
CPD. Twelve hours after UVB irradiation, genomic DNA 
was isolated from treated cells and assayed for UV-induced 
DNA damage using lesion-specific antibodies. An average of 
fifty-five CPD and twelve 6-4PP lesions per million bases 
were detected after exposure to 300 J/m2 UVB. Results are 
the average of duplicate assays from two independent exper-
iments. Error bars show standard deviation.
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Detection of photolyase expression and function Figure 2
Detection of photolyase expression and function. Pho-
tolyase expression was confirmed by western blots of whole 
cell lysates from stably transfected XPA cell lines containing 
empty vector or both photolyases. Blots were probed with 
antibodies specific for CPD-PL (A) and 6-4PP-PL (B). Photol-
yase repair of UV induced DNA damage in XPA cells was 
detected by immuno-dot-blot, using the same antibodies. 
Representative examples of 6-4PP (C) and CPD (D) lesion 
studies are shown.
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pApA [21] does not increase melanogenesis indicating the
effect of pTpT in mimicking CPD lesions.
UV can upregulate the death receptor apoptotic pathway
to eradicate DNA damaged cells [23,24]. Lymphocytes are
especially sensitive to DNA damage-induced apoptosis.
Jurkat cells, a human T-cell line, provides a well-estab-
lished model for death receptor (Fas-FasL) mediated
apoptosis in response to either UV and/or
chemotherapeutic drugs [25]. We examined if pTpT could
induce Fas-FasL mediated apoptosis in vitro and in vivo.
The addition of pTpT to Jurkat cells stalled the cell cycle,
but did not induce FasL (data not shown) or apoptosis (as
seen by sub-diploid peak analysis, Fig. 4A). Jurkat cells
exposed to the same concentration of control oligonucle-
otide, pApA, did not show any cell cycle disruption or
increased apoptosis. The relative percentage cells in each
phase of the cell cycle for pTpT- and pApA-treated cells is
shown in Fig. 4B. Note the increased proportion of cells in
S-phase and decreased proportion of cells in G2/M phase
for pTpT treated cells as compared to controls and pApA
treated cells.
We also tested whether pTpT could alter FasL-mediated
apoptosis in an established in vivo model. For these exper-
iments, solvent containing 200 µM pTpT or 200 µM pApA
was applied on the shaved dorsal skin of C57BL/6 mice.
Mice exposed to a single dose of 4 kJ/m2 of UVB were used
as positive controls. Apoptosis was assessed on paraffin
embedded formaldehyde-fixed skin biopsies using the
DeadEnd Fluorometric TUNEL System (Promega).
Although UV-induced apoptosis was observed 12 hours
after UV treatment and continued to increase at least until
24 hours following UV exposure (Fig 5A), pTpT did not
induce apoptosis in vivo in concert with our findings in
vitro (Fig. 5B). Taken together, our findings suggest that
pTpT, the mimic of CPD, is not a potent inducer of apop-
tosis, but inhibits cell cycle progression. Similar results
have been observed with human melanocytes in vitro,
where pTpT has been shown to induces melanogenesis
and stall the cell cycle in the absence of increased apopto-
sis [22].
Our finding that repair of 6-4 PP lesions was more effec-
tive in the blockade of apoptosis than the repair of CPD
lesions would seem to be contradictory to published find-
ings that transgenic mice expressing the CPD photolyase
in the skin showed dramatically reduced levels of UV-
induced apoptosis, erythema, and hyperplasia [13]. One
underlying factor that may contribute to the effects of
CPD on apoptosis induction is the p53 status of the cell.
Because we [9] have shown that p53 can induce upregula-
tion of death receptors such as Fas which plays a key role
in UV-induced apoptosis in vivo  [26], it is imperative to
consider the p53 status of the cells/animals used for study.
In the case of the XP cells used for the current studies, p53
is mutant (data not shown). When p53 is wild-type, CPD
lesions may be more robust in the induction of apoptosis.
Other studies have shown that transgenic animals express-
ing the CPD photolyase show superior resistance to sun-
light-induced carcinogenesis [27]. These findings may
relate to the fact that UV-induced apoptosis is decreased in
the skin of chronically irradiated mice consistent with the
induction p53 mutations [23]. Alternately stated, when
p53 is wild-type CPD lesions may be a more powerful
inducer of apoptosis, however, once p53 becomes
mutated (as is commonly observed for non-melanoma
skin cancers) CPD lesions may act to induce cell cycle
arrest. It will be especially interesting to examine tran-
scription coupled repair efficiency following photolyase
treatments in wild-type and mutant p53 containing cells
as reports have indicated that transcription coupled repair
efficiency can determine cell cycle progression and apop-
tosis in UV-irradiated cells [28]. Future studies will
address the impact of p53 status on the biological effects
of CPD and 6-4 PP lesion repair as well as the effects of
such repair on transcription coupled repair and global
genome repair.
Impact of photoreactivation on UVB-induced apoptosis Figure 3
Impact of photoreactivation on UVB-induced apop-
tosis. Apoptosis in XPA cells was monitored at a 24 hour 
time point following exposure to 300 J/m2 UV and photore-
activation-induced repair. Apoptosis was examined by PI 
staining and FACS, gating the sub-G1 population as apoptotic. 
Apoptotic values were normalized to empty vector contain-
ing cells (amount of apoptosis set as 100%). Bar graphs show 
the relative amount of apoptosis for control cells, cells 
expressing CPD-PL alone (40% rescue), cells expressing 6-
4PP-PL alone (70% rescue), or cell expressing both-PLs (75% 
rescue).
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Effects of pTpT on cell cycle and apoptosis in vitro Figure 4
Effects of pTpT on cell cycle and apoptosis in vitro. A. Jurkat cells were exposed to pTpT (100 µM) or pApA (100 µM) 
in vitro and cell cycle analysis performed after 1 and 24 hours by flow cytometry as described in Materials and Methods. Results 
show representative histograms from five independent experiments. Note that only pTpT stalls the cell cycle, not pApA, and 
no increase in apoptotic sub-G1 DNA content was observed with either pTpT or pApA. B. Bar graph showing percentage of 
cells in each phase of the cell cycle in cells treated with pTpT or pApA for 24 hrs.
24 hr 1 hr
pApA
pTpT
No
Treatment
DNA Content
C
e
l
l
 
N
u
m
b
e
r
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
No Treatment pApA pTpT
C
e
l
l
 
C
y
c
l
e
%
Go/G1
S
G2BMC Cancer 2005, 5:135 http://www.biomedcentral.com/1471-2407/5/135
Page 7 of 9
(page number not for citation purposes)
CPD mimic, pTpT, does not induce apoptosis in vivo Figure 5
CPD mimic, pTpT, does not induce apoptosis in vivo. TUNEL-stained sections from mouse dorsal skin coated with 
pTpT or pApA, or exposed to a single dose 4 kJ/m2 UVB as a positive control. (A) Green fluorescence indicates 3' DNA 
breaks, representative of apoptotic cells. (B) Numbers of TUNEL positive cells in skin sections from three separate experi-
ments, consisting of three mice in each experimental group. Apoptotic values indicate the number of TUNEL-positive cells by 
tissue length. Pictures were taken on a Nikon ECLIPSE TE2000-U microscope under FITC illumination at 400×.
24
Control
pApA 24h
pTpT 24h UVB 12h
UVB 24h
Control
0
40
80
120
160
A
p
o
p
t
o
t
i
c
 
T
U
N
E
L
 
P
o
s
i
t
i
v
e
 
C
e
l
l
 
N
u
m
b
e
r
s
/
c
m
Control pApA 24h pTpT 24h UVB 24h UVB 12hBMC Cancer 2005, 5:135 http://www.biomedcentral.com/1471-2407/5/135
Page 8 of 9
(page number not for citation purposes)
Conclusion
The UVB-induced DNA lesions, CPD and 6-4PP, show dif-
ferential biological effects with respect to the induction of
apoptosis and cell cycle arrest. CPD lesions are the most
abundant following UVB exposure and photolyase-
induced repair of these lesions decreased the overall apop-
totic response by approximately 40% compared with cells
receiving no PR repair. Repair of 6-4PP lesions which
account for approximately 20% of the total UV-induced
DNA damage, on the other hand, decreased the overall
apoptotic response by approximately 75% (almost equiv-
alent to that using both CPD and 6-4PP photolyases
together). These findings suggest that the 6-4 PP lesion is
more potent in the induction of UV-induced apoptosis. In
contrast, the CPD lesion appears to be more potent in the
induction of cell cycle arrest. Using the CPD mimic, pTpT,
we documented that cell cycle arrest occurred in vitro after
treatment in the absence of increased apoptosis. Similar
findings were also observed in vivo using the pTpT molec-
ular mimic of CPD lesions. Therefore CPD lesions will
halt the cell cycle to effect repair that may or may not elim-
inate the damage, thus increasing the relative probability
that these kinds of lesions will accumulate leading to
mutation. In support of this premise, You et al. [10] have
documented that CPD lesions account for the majority of
UV-induced mutations in mammalian cells. The more
potent apoptosis-inducing activity of 6-4PP lesions may
induce apoptosis and "erase" the damaged cell, thus
decreasing its carcinogenic potential.
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